CIMS Global

The recent R Consortium update highlights the momentum behind R’s adoption in regulatory submissions, with industry leaders collaborating to enhance standardization, validation, and compliance. At CIMS Global, we are pioneering R-driven innovations that streamline the submission process, ensuring transparency, efficiency, and reproducibility for sponsors. As regulatory bodies continue to recognize R’s power, CIMS Global stands ready to support sponsors with best-in-class R-based submission strategies. Let’s shape the future of regulatory submissions—together! ?? Interested in leveraging R for your next submission? Let’a connect Tai Xie, Ph.D. Peng Zhang #RegulatorySubmissions #ClinicalTrials #RStats #Pharma #Biotech #CIMSGlobal

?? We’re Headed to the Florida Sunshine Again! ?? Join us at PHUSE US Connect 2025 from March 16-19 in Orlando! Find us at Booth #17 and don't miss our insightful presentations lead by our finest talent! ?? Discover how automation with {quarto} & {shiny} can streamline the CSR writing process, reducing completion time from months to just a few weeks. Join us on March 17, 2:30-3:00 PM @ Ocean 11 ?? Learn how {teal} Shiny Apps enhance Data Monitoring Committee workflows for more efficient decision-making on?March 17, 4:30-5:00pm @ Ocean 11 ?? Explore how AI-driven automation is transforming statistical output validation for faster, more accurate reviews on?March 18, 12:00-12:30pm @ Ocean 12 Learn more about phuse here: https://lnkd.in/eH3m7Ugp #PHUSEUSConnect #ClinicalData #AI #ShinyApps #Automation #DataMonitoring #GenAI #ClinicalTrials

Get ready to be motivated by their wisdom and achievements of these incredible women in Science! Who inspires you the most? Drop a comment below! #WomenInScience #STEM #Inspiration #Trailblazers #ScienceMatters #womenandgirlsinscience

At SCOPE 2025, our CEO & Founder, Tai Xie, Ph.D. delivered a compelling presentation on our innovative approach to dynamic trial design. This method considers every aspect of a clinical trial, from subject recruitment to study endpoints. A big thank you to everyone who joined us at the event. Feel free to get in touch if you're interested in discovering how our statistical model can help your clinical trials. #scope2025 #AI #Clinicaltrials

We are here! Come say hi at booth #924

We’re excited to connect with you at the SCOPE Summit 2025 in Orlando from February 3–6! Don’t miss our session on February 6, led by our very own Tai Xie, Ph.D., who will share insights on Dynamic Trial Monitoring for Ongoing Clinical Trials. Be sure to visit us at Booth #924 to meet the team and explore how our innovative solutions can support your clinical trial success. See you there! #SCOPE2025 #ClinicalTrials #Innovation #DynamicTrialMonitoring

Join us online for the Bay Area Biotech-Pharma Statistics Workshop Meetup on Friday, January 31. This is a unique opportunity to learn innovative approaches to data-driven decisions in clinical trials and network with stellar professionals. We're proud to announce that our very own Joe Shih, PhD, and Peng Zhang, PhD, will be sharing their expertise as panelists! Register here: https://lnkd.in/eEeRMViW

We’re excited to connect with you at the SCOPE Summit 2025 in Orlando from February 3–6! Don’t miss our session on February 6, led by our very own Tai Xie, Ph.D., who will share insights on Dynamic Trial Monitoring for Ongoing Clinical Trials. Be sure to visit us at Booth #924 to meet the team and explore how our innovative solutions can support your clinical trial success. See you there! #SCOPE2025 #ClinicalTrials #Innovation #DynamicTrialMonitoring

The new FDA's proposed framework to enhance the credibility of AI models for drug and biological product submissions reaffirms the industry's direction toward integrating cutting-edge technology with regulatory excellence. As the regulatory landscape evolves, we are ready to partner with industry leaders to bring transformative AI-driven approaches to clinical trials. Let’s ensure every trial is a step closer to innovation, safety, and efficacy. Together, we can build trust in AI for a healthier future. ?? Learn more: https://lnkd.in/gYSDtjA2 Would you like to explore a collaboration? Let’s connect! ?? #CIMSGlobal #AIinClinicalTrials #Innovation #Safety #Efficacy #DDM #GenAI #ClinicalTrials #FDA

?? Wrapping Up 2024: A Year of Growth, Innovation, and Gratitude??? As we close 2024, all of us at CIMS Global want to take a moment to reflect on an incredible year and share our heartfelt gratitude with everyone who has been part of our journey. ?? Learning and Growing This year’s challenges became opportunities, teaching us valuable lessons and sharpening our focus on delivering excellence. ?? Celebrating New Partnerships We’re thrilled to have welcomed several new organizations to the CIMS Global family. We look forward to achieving great milestones together. ?? Engaging with the Industry From participating in pivotal conferences like JSM and others, we connected with brilliant minds, exchanged ideas, and strengthened our industry presence. ?? Advancing with New Product Development 2024 saw major milestones, including the launch of new DMC Services and Tools, aligned with FDA guidelines for Data Monitoring Committees (DMCs). These innovations ensure we continue setting industry standards. ?? Investing in Innovative Technology Our commitment to innovation led to the expansion of our capabilities that streamline processes, including R FDA package submissions and expanded in-house expertise, keeping us ahead in the competitive landscape. ?? Expanding our Team We’re proud to have expanded our team, bringing in talented individuals who share our passion for innovation and client success. Looking Ahead As we step into a new year, our mission is clear: continue redefining industry standards with cutting-edge technology and unparalleled service. To our clients, partners, and team members: thank you for being part of our story. Here’s to an even brighter 2025! #CIMSGlobal #YearInReview #Innovation #Growth #ThankYou #NewBeginnings